Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.

Detalhes bibliográficos
Autor(a) principal: Ribeiro, R
Data de Publicação: 2017
Outros Autores: Silvestre, C, Duarte, C
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/1919
Resumo: The alternative medicines are commonly used, especially herbal ones. Among them, boldo is traditionally used for symptomatic treatment of dyspepsia and mild gastrointestinal spasmodic disorders. Nevertheless, the number of reported cases of possible hepatotoxicity of some of these products has increased, including one report of boldo-induced hepatitis. We present the case of a 72-year-old female patient who has developed jaundice and increased serum levels of liver enzymes, after repeated consumption of boldo leaves infusion, during 2 weeks. After exclusion of common causes of hepatobiliary pathology, boldo-induced hepatotoxicity was considered probable. Interrupting of ingestion led to clinical and laboratorial recovery. This case proves the value of research in the alternative medicines' use. Ingestion of boldo, particularly in elderly patients with biliary tract disorders, may be the cause of otherwise unexplained jaundice or abnormal values of liver enzymes.
id RCAP_cfc41f8b93a03f7e4fd64c68e31cc0c5
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1919
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.Medicinas alternativasTerapias complementaresDoença hepática induzida por substâncias e medicamentosIcteríciaThe alternative medicines are commonly used, especially herbal ones. Among them, boldo is traditionally used for symptomatic treatment of dyspepsia and mild gastrointestinal spasmodic disorders. Nevertheless, the number of reported cases of possible hepatotoxicity of some of these products has increased, including one report of boldo-induced hepatitis. We present the case of a 72-year-old female patient who has developed jaundice and increased serum levels of liver enzymes, after repeated consumption of boldo leaves infusion, during 2 weeks. After exclusion of common causes of hepatobiliary pathology, boldo-induced hepatotoxicity was considered probable. Interrupting of ingestion led to clinical and laboratorial recovery. This case proves the value of research in the alternative medicines' use. Ingestion of boldo, particularly in elderly patients with biliary tract disorders, may be the cause of otherwise unexplained jaundice or abnormal values of liver enzymes.Informa HealthcareRepositório do Hospital Prof. Doutor Fernando FonsecaRibeiro, RSilvestre, CDuarte, C2017-08-07T13:33:23Z2017-01-01T00:00:00Z2017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/1919engJ Diet Suppl. 2017 Mar 4;14(2):186-1901939-022X10.1080/19390211.2016.1207123metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:52:39Zoai:repositorio.hff.min-saude.pt:10400.10/1919Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:52:56.884300Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
title Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
spellingShingle Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
Ribeiro, R
Medicinas alternativas
Terapias complementares
Doença hepática induzida por substâncias e medicamentos
Icterícia
title_short Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
title_full Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
title_fullStr Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
title_full_unstemmed Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
title_sort Hidden Risks of Alternative Medicines: A Case of Boldo-Induced Hepatotoxicity.
author Ribeiro, R
author_facet Ribeiro, R
Silvestre, C
Duarte, C
author_role author
author2 Silvestre, C
Duarte, C
author2_role author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Ribeiro, R
Silvestre, C
Duarte, C
dc.subject.por.fl_str_mv Medicinas alternativas
Terapias complementares
Doença hepática induzida por substâncias e medicamentos
Icterícia
topic Medicinas alternativas
Terapias complementares
Doença hepática induzida por substâncias e medicamentos
Icterícia
description The alternative medicines are commonly used, especially herbal ones. Among them, boldo is traditionally used for symptomatic treatment of dyspepsia and mild gastrointestinal spasmodic disorders. Nevertheless, the number of reported cases of possible hepatotoxicity of some of these products has increased, including one report of boldo-induced hepatitis. We present the case of a 72-year-old female patient who has developed jaundice and increased serum levels of liver enzymes, after repeated consumption of boldo leaves infusion, during 2 weeks. After exclusion of common causes of hepatobiliary pathology, boldo-induced hepatotoxicity was considered probable. Interrupting of ingestion led to clinical and laboratorial recovery. This case proves the value of research in the alternative medicines' use. Ingestion of boldo, particularly in elderly patients with biliary tract disorders, may be the cause of otherwise unexplained jaundice or abnormal values of liver enzymes.
publishDate 2017
dc.date.none.fl_str_mv 2017-08-07T13:33:23Z
2017-01-01T00:00:00Z
2017-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/1919
url http://hdl.handle.net/10400.10/1919
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv J Diet Suppl. 2017 Mar 4;14(2):186-190
1939-022X
10.1080/19390211.2016.1207123
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Informa Healthcare
publisher.none.fl_str_mv Informa Healthcare
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130395765112832